Publication | Closed Access

Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion

Trastuzumab ResistanceAutoimmune DiseaseImmunologyTumor ImmunityImmunodominanceIfnγ SecretionImmune Effector CellsAutoimmunityT Cell ImmunityImmunologic MechanismImmune FunctionCellular Immune ResponseImmunotherapyMedicineCell BiologyCell Signaling